INVO Fertility, Inc. (IVF)
NASDAQ: IVF · Real-Time Price · USD
1.000
-0.030 (-2.91%)
At close: Aug 28, 2026, 4:00 PM EDT
1.010
+0.010 (1.00%)
After-hours: Aug 28, 2026, 7:22 PM EDT
Company Description
INVO Fertility, Inc., a healthcare services company, focuses on the fertility marketplace that provides assisted reproductive technology care to patients.
It operates through Fertility Clinic Services and INVOcell Device segments. The company offers INVOcell Device, a medical device that allows fertilization and early embryo development to take place in vivo within the woman’s body.
It also operates fertility clinics, including INVO Centers. The company was formerly known as NAYA Biosciences, Inc. and changed its name to INVO Fertility, Inc. in April 2025.
INVO Fertility, Inc. was founded in 2007 and is based in Sarasota, Florida.
INVO Fertility, Inc.
| Country | United States |
| Founded | 2007 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 42 |
| CEO | Steven Shum |
Contact Details
Address: 5582 Broadcast Court Sarasota, Florida 34240 United States | |
| Phone | 978 878 9505 |
| Website | invofertility.com |
Stock Details
| Ticker Symbol | IVF |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001417926 |
| CUSIP Number | 44984F880 |
| ISIN Number | US44984F8804 |
| Employer ID | 20-4036208 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Steven M. Shum | Chief Executive Officer and Director |
| Terah Krigsvold | Chief Financial Officer |
| Andrea Goren | Chief Business Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Aug 28, 2026 | S-8 | Securities to be offered to employees in employee benefit plans |
| Aug 28, 2026 | 8-K | Current Report |
| Aug 17, 2026 | 8-K | Current Report |
| Aug 14, 2026 | 10-Q | Quarterly Report |
| Aug 14, 2026 | SCHEDULE 13G/A | Filing |
| Aug 7, 2026 | SCHEDULE 13G | Filing |
| Aug 7, 2026 | 424B3 | Prospectus |
| Aug 4, 2026 | EFFECT | Notice of Effectiveness |
| Jul 24, 2026 | S-1 | General form for registration of securities under the Securities Act of 1933 |
| Jul 24, 2026 | 8-K | Current Report |